Your browser doesn't support javascript.
loading
The Role of MHC-E in T Cell Immunity Is Conserved among Humans, Rhesus Macaques, and Cynomolgus Macaques.
Wu, Helen L; Wiseman, Roger W; Hughes, Colette M; Webb, Gabriela M; Abdulhaqq, Shaheed A; Bimber, Benjamin N; Hammond, Katherine B; Reed, Jason S; Gao, Lina; Burwitz, Benjamin J; Greene, Justin M; Ferrer, Fidel; Legasse, Alfred W; Axthelm, Michael K; Park, Byung S; Brackenridge, Simon; Maness, Nicholas J; McMichael, Andrew J; Picker, Louis J; O'Connor, David H; Hansen, Scott G; Sacha, Jonah B.
Afiliação
  • Wu HL; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006.
  • Wiseman RW; Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI 53706.
  • Hughes CM; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006.
  • Webb GM; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006.
  • Abdulhaqq SA; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006.
  • Bimber BN; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006.
  • Hammond KB; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006.
  • Reed JS; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006.
  • Gao L; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006.
  • Burwitz BJ; Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239.
  • Greene JM; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006.
  • Ferrer F; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006.
  • Legasse AW; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006.
  • Axthelm MK; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006.
  • Park BS; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006.
  • Brackenridge S; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006.
  • Maness NJ; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006.
  • McMichael AJ; School of Public Health, Oregon Health and Science University, Portland, OR 97239.
  • Picker LJ; Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX1 2JD, United Kingdom.
  • O'Connor DH; Division of Microbiology, Tulane National Primate Research Center, Covington, LA 70433.
  • Hansen SG; Department of Microbiology and Immunology, School of Medicine, Tulane University Health Sciences Center, New Orleans, LA 70118; and.
  • Sacha JB; Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX1 2JD, United Kingdom.
J Immunol ; 200(1): 49-60, 2018 01 01.
Article em En | MEDLINE | ID: mdl-29150562
MHC-E is a highly conserved nonclassical MHC class Ib molecule that predominantly binds and presents MHC class Ia leader sequence-derived peptides for NK cell regulation. However, MHC-E also binds pathogen-derived peptide Ags for presentation to CD8+ T cells. Given this role in adaptive immunity and its highly monomorphic nature in the human population, HLA-E is an attractive target for novel vaccine and immunotherapeutic modalities. Development of HLA-E-targeted therapies will require a physiologically relevant animal model that recapitulates HLA-E-restricted T cell biology. In this study, we investigated MHC-E immunobiology in two common nonhuman primate species, Indian-origin rhesus macaques (RM) and Mauritian-origin cynomolgus macaques (MCM). Compared to humans and MCM, RM expressed a greater number of MHC-E alleles at both the population and individual level. Despite this difference, human, RM, and MCM MHC-E molecules were expressed at similar levels across immune cell subsets, equivalently upregulated by viral pathogens, and bound and presented identical peptides to CD8+ T cells. Indeed, SIV-specific, Mamu-E-restricted CD8+ T cells from RM recognized antigenic peptides presented by all MHC-E molecules tested, including cross-species recognition of human and MCM SIV-infected CD4+ T cells. Thus, MHC-E is functionally conserved among humans, RM, and MCM, and both RM and MCM represent physiologically relevant animal models of HLA-E-restricted T cell immunobiology.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Antígenos de Histocompatibilidade Classe I / Linfócitos T CD4-Positivos / Síndrome de Imunodeficiência Adquirida dos Símios / Vírus da Imunodeficiência Símia / Linfócitos T CD8-Positivos / Antígenos de Histocompatibilidade Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Antígenos de Histocompatibilidade Classe I / Linfócitos T CD4-Positivos / Síndrome de Imunodeficiência Adquirida dos Símios / Vírus da Imunodeficiência Símia / Linfócitos T CD8-Positivos / Antígenos de Histocompatibilidade Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article